Polymer therapeutics--polymers as drugs, drug and protein conjugates and gene delivery systems: past, present and future opportunities.
about
Nanopharmaceuticals (part 2): products in the pipelineTargeting angiogenesis-dependent calcified neoplasms using combined polymer therapeuticsPerspective highlights on biodegradable polymeric nanosystems for targeted therapy of solid tumorsUse of a nanoporous biodegradable miniature device to regulate cytokine release for cancer treatmentReview of Long-Wavelength Optical and NIR Imaging Materials: Contrast Agents, Fluorophores and Multifunctional Nano CarriersAcute and impaired wound healing: pathophysiology and current methods for drug delivery, part 2: role of growth factors in normal and pathological wound healing: therapeutic potential and methods of delivery.Engineered Protein Polymer-Gold Nanoparticle Hybrid Materials for Small Molecule DeliveryDrug-initiated ring-opening polymerization of O-carboxyanhydrides for the preparation of anticancer drug-poly(O-carboxyanhydride) nanoconjugatesPoly(amido amine) dendrimers in oral delivery.Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dosePeptide modified mesoporous silica nanocontainers.Image-guided nanosystems for targeted delivery in cancer therapy.Radiolabelled Polymeric Materials for Imaging and Treatment of Cancer: Quo Vadis?Improved anti-tumor efficiency against prostate cancer by docetaxel-loaded PEG-PCL micelles.A ligand-mediated nanovector for targeted gene delivery and transfection in cancer cells.Degradable Cross-Linked Nanoassemblies as Drug Carriers for Heat Shock Protein 90 Inhibitor 17-N-Allylamino-17-demethoxy-geldanamycin.The effect of novel nitrogen-rich plasma polymer coatings on the phenotypic profile of notochordal cells.A new developing class of gene delivery: messenger RNA-based therapeutics.HIF-1α inhibition by diethylstilbestrol and its polyacetal conjugate in hypoxic prostate tumour cells: insights from NMR metabolomics.
P2860
Q26824153-C3DBC3B0-FB8C-43BF-BE4C-D07C87804CA6Q33432776-4C6764C5-CC75-4F79-B782-860102BBD455Q33712145-4FACF791-6CC7-4228-BF04-3D4DE6C9CEF8Q33828167-AE5305BE-8149-49CA-8E30-A77BA38E7E08Q36176439-BAF5201E-2228-45ED-866F-EBAB3B7CB2F7Q36186814-CB36CAD4-E619-40F7-86F1-391B500E98EFQ36790660-A462EDBF-9424-4702-85E1-28ED1EA4A16FQ36899044-D47E05EB-1D8C-43C8-AC7F-72D20E600A3AQ37012935-CAA74EE6-D3AD-4392-A3F1-3D38C200853EQ37126611-DBD29329-556A-4F45-A1A3-CAC58561BA03Q37487102-8B0D4EF4-31CB-425F-95B5-94BA8C12B1C2Q38011794-7C594F74-BDFE-4F21-8526-32BF37F1EB6EQ38755295-D8285023-5F73-4147-B5D9-66AC0187364CQ39027223-3B360EAD-CFA6-4526-BB38-32C1438617E6Q39920259-2EC45B22-64F4-4C39-9356-5BD9003231F8Q40783792-C09883C3-97E8-4612-B32D-814213032102Q42161196-753DE5A1-18C4-4C37-AB96-654CE407BA2CQ45873514-ED1715F0-2DC3-4795-B414-3F9267D5460EQ54702281-C38B8291-6611-463F-8C36-2630A37650D7
P2860
Polymer therapeutics--polymers as drugs, drug and protein conjugates and gene delivery systems: past, present and future opportunities.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Polymer therapeutics--polymers ...... sent and future opportunities.
@ast
Polymer therapeutics--polymers ...... sent and future opportunities.
@en
type
label
Polymer therapeutics--polymers ...... sent and future opportunities.
@ast
Polymer therapeutics--polymers ...... sent and future opportunities.
@en
prefLabel
Polymer therapeutics--polymers ...... sent and future opportunities.
@ast
Polymer therapeutics--polymers ...... sent and future opportunities.
@en
P2860
P1476
Polymer therapeutics--polymers ...... sent and future opportunities.
@en
P2093
Helmut Ringsdorf
Ruth Duncan
P2860
P304
P356
10.1080/10611860600833856
P577
2006-07-01T00:00:00Z